← Back to Search

Antimicrobial Agent

Stannous Fluoride Toothpaste + CPC Mouthwash for Gum Disease

N/A
Recruiting
Research Sponsored by HALEON
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant in good general and mental health with no clinically significant abnormalities
Participant is at least 18 years old
Must not have
Pregnant or breastfeeding female participants
Participant with periodontal and dental exclusions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 6 and week 12
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if using a specific mouthwash and toothpaste together can improve gum health and reduce plaque better than just using a regular toothpaste in people with gum disease caused by plaque."

Who is the study for?
This trial is for individuals with plaque-induced gingivitis, which means they have gum disease and a noticeable buildup of plaque on their teeth. Participants should be looking to improve their gum health.
What is being tested?
The study compares the effectiveness of two oral care routines: one uses Stannous Fluoride Toothpaste with CPC Mouthwash, and the other uses Regular Fluoride Toothpaste alone. The goal is to see which routine is better at improving gum health and reducing plaque.
What are the potential side effects?
Possible side effects may include tooth staining, a change in taste perception, or mouth irritation from using stannous fluoride toothpaste or CPC mouthwash. These are typically mild but can vary among individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am in good physical and mental health with no major health issues.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently pregnant or breastfeeding.
Select...
I do not have major dental or gum problems.
Select...
I do not have severe oral health issues that could affect the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 6 and week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6 and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Overall Number of Bleeding Sites (NBS) at Week 12 (Toothpaste/Mouthwash versus [vs.] Negative Control Toothpaste)
Secondary study objectives
Interproximal Mean BI at Weeks 6 and 12 (Reference Toothpaste vs. Negative Control Toothpaste)
Interproximal Mean BI at Weeks 6 and 12 (Toothpaste/Mouthwash vs. Negative Control Toothpaste)
Interproximal Mean MGI at Weeks 6 and 12 (Reference Toothpaste vs. Negative Control Toothpaste)
+14 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Toothpaste/Mouthwash (SnF2 Toothpaste followed by CPC Mouthwash)Experimental Treatment2 Interventions
Participants will brush their teeth with full ribbon of test toothpaste containing SnF2 on head of toothbrush provided for at least one (timed) minute twice daily (morning and evening) for 12 weeks. After each brushing, participants will swish 20 milliliters (mL) of the mouthwash containing CPC vigorously between teeth for 30 seconds twice daily (morning and evening) for 12 weeks.
Group II: Negative Control Toothpaste (Sodium Fluoride Toothpaste)Active Control1 Intervention
Participants will brush their teeth with full ribbon of negative control toothpaste containing sodium fluoride on head of toothbrush provided for at least one (timed) minute twice daily (morning and evening) for 12 weeks.
Group III: Reference Toothpaste (SnF2 Toothpaste)Active Control1 Intervention
Participants will brush their teeth with full ribbon of reference toothpaste containing SnF2 on head of toothbrush provided for at least one (timed) minute twice daily (morning and evening) for 12 weeks.

Find a Location

Who is running the clinical trial?

HALEONLead Sponsor
37 Previous Clinical Trials
5,700 Total Patients Enrolled
~132 spots leftby Mar 2025